GSK — GSK Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for GSK, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	24,696	29,324	30,328	31,376	32,667
Cost of Revenue
Gross Profit	16,690	20,857	21,965	22,559	23,739
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	20,375	22,891	23,582	27,349	24,735
Operating Profit	4,321	6,433	6,746	4,027	7,932
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,599	5,628	6,064	3,477	7,401
Provision for Income Taxes
Net Income After Taxes	3,516	4,921	5,308	2,951	6,289
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	4,385	14,956	4,928	2,575	5,716
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,385	14,956	4,928	2,575	5,716
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.681	1.14	1.4	1.13	1.56
Dividends per Share